These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32677329)

  • 1. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak.
    Chiesa-Estomba CM; Lechien JR; Radulesco T; Michel J; Sowerby LJ; Hopkins C; Saussez S
    Eur J Neurol; 2020 Nov; 27(11):2318-2321. PubMed ID: 32677329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of olfactory impairment in patients with otherwise paucisymptomatic coronavirus disease 2019 during the pandemic.
    Jalessi M; Bagheri SH; Azad Z; Firouzabadi FD; Amini E; Alizadeh R; Chaibakhsh S; Ghalehbaghi B; Hopkins C; Farhadi M
    J Laryngol Otol; 2021 May; 135(5):426-435. PubMed ID: 33883051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection of Platelet Rich Plasma in the Olfactory Cleft for COVID-19 Patients With Persistent Olfactory Dysfunction: Description of the Technique.
    Lechien JR; Saussez S
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):115S-119S. PubMed ID: 36219733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Platelet-Rich Plasma for COVID-19-Related Olfactory Dysfunction: A Controlled Study.
    Lechien JR; Saussez S; Vaira LA; De Riu G; Boscolo-Rizzo P; Tirelli G; Michel J; Radulesco T
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):84-91. PubMed ID: 37522295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of smell recovery in a nationwide prospective cohort of patients with COVID-19.
    Coelho DH; Reiter ER; Budd SG; Shin Y; Kons ZA; Costanzo RM
    Am J Otolaryngol; 2022; 43(1):103239. PubMed ID: 34547716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Frequency-Controlled Ear Acupuncture on COVID-19- related Refractory Olfactory Dysfunction: a Randomized Clinical Trial.
    Mohebbi A; Bagheri SH; Raziabadi E; Shafiei A; Roomiani M; Arab M; Dehdari L
    J Acupunct Meridian Stud; 2024 Apr; 17(2):69-75. PubMed ID: 38686430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Efficacy of Nasal Corticosteroids in COVID-19-Related Olfactory Dysfunction: A Comprehensive Systematic Review and Meta-analysis.
    Chen RD; Yang CW; Chen XB; Hu HF; Cui GZ; Zhu QR; Kuang MJ
    Otolaryngol Head Neck Surg; 2024 Apr; 170(4):999-1008. PubMed ID: 38124278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Insulin for the Treatment of Persistent Post-COVID-19 Olfactory Dysfunction.
    Cherobin GB; Guimarães RES; de Paula Gomes MC; Vasconcelos LOG; de Abreu LAN
    Otolaryngol Head Neck Surg; 2023 Sep; 169(3):719-724. PubMed ID: 37078341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 related parosmia: an exploratory survey of demographics and treatment strategies.
    Sowerby LJ; Almubarak Z; Biadsee A; Rocha T; Hopkins C
    J Laryngol Otol; 2023 Nov; 137(11):1256-1260. PubMed ID: 37194063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Persistent olfactory impairment after COVID-19-recommendations of the Working Group on Olfactology and Gustology of the German Society of Oto-rhino-laryngology, Head and Neck Surgery].
    Hintschich CA; Wege-Lüssen A; Göktas Ö; Stuck BA; Müller CA; Hummel T
    HNO; 2023 Nov; 71(11):739-743. PubMed ID: 37801102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of platelet-rich plasma on post-COVID chronic olfactory dysfunction.
    Evman MD; Cetin ZE
    Rev Assoc Med Bras (1992); 2023; 69(11):e20230666. PubMed ID: 37909619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual-Olfactory Training and Patient Preference in Treatment of COVID-19 Olfactory Loss-How Salient Stimuli Might Support Recovery of Smell.
    Di Stadio A; D'Ascanio L; Brenner MJ
    JAMA Otolaryngol Head Neck Surg; 2023 Jul; 149(7):650. PubMed ID: 37261815
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual-Olfactory Training and Patient Preference in Treatment of COVID-19 Olfactory Loss-How Salient Stimuli Might Support Recovery of Smell-Reply.
    Khan AM; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Jul; 149(7):651. PubMed ID: 37261823
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperbaric oxygen therapy for treatment of COVID-19-related parosmia: a case report.
    Krimus L; Hasan Rizvi S; Marinov A; Clarke H; Katznelson R
    Undersea Hyperb Med; 2023; 50(4):433-435. PubMed ID: 38055885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID-19) pandemic in the United States: Urgent need for clinical trials.
    Lechner M; Liu J; Counsell N; Yan CH; Paun S; Eynon-Lewis N; Sutton L; Jayaraj S; Batterham RL; Hopkins C; Philpott C; Lund VJ; Hatter M; Abdelwahab M; Holsinger FC; Capasso R; Nayak JV; Hwang PH; Patel ZM
    Int Forum Allergy Rhinol; 2023 Aug; 13(8):1558-1560. PubMed ID: 36409559
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Postinfectious Olfactory Dysfunction Using Corticosteroids.
    Duan HG; Ji F; Yan MX
    Ear Nose Throat J; 2024 Feb; 103(2):NP108-NP112. PubMed ID: 34464164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensory function recovery in COVID-19 patients: A cross-sectional study.
    Nawab A; Acosta A; Levine CG; Hoffer ME; Casiano R; Liu XZ
    Am J Otolaryngol; 2024; 45(1):104047. PubMed ID: 37738881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunotherapy with M2 macrophage soluble factors in post-COVID hyposmia: A pilot study.
    Shevela EY; Davydova MN; Meledina IV; Bogachev SS; Ostanin AA; Kozlov VA; Chernykh ER
    Int Immunopharmacol; 2024 Jan; 126():111260. PubMed ID: 38000231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination may help patients with persistent COVID-19 smell dysfunction.
    Lechien JR; Hopkins C; Vaira LA; Saussez S
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):3S-4S. PubMed ID: 34569299
    [No Abstract]   [Full Text] [Related]  

  • 20. What Is Different in COVID-19-Associated Olfactory Loss from Classical Postinfectious Olfactory Impairment?
    Landis BN; Hsieh JW; Konstantinidis I; Holbrook EH; Huart C; Mori E; Hummel T
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):245-247. PubMed ID: 37591225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.